Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Non-Current Assets (2022 - 2025)

Coya Therapeutics' Non-Current Assets history spans 4 years, with the latest figure at $18068.0 for Q3 2025.

  • For Q3 2025, Non-Current Assets fell 60.23% year-over-year to $18068.0; the TTM value through Sep 2025 reached $113312.0, down 49.13%, while the annual FY2024 figure was $38588.0, 41.49% down from the prior year.
  • Non-Current Assets for Q3 2025 was $18068.0 at Coya Therapeutics, down from $24908.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.2 million in Q4 2022 and bottomed at $18068.0 in Q3 2025.
  • The 4-year median for Non-Current Assets is $55689.0 (2024), against an average of $148796.5.
  • The largest annual shift saw Non-Current Assets tumbled 94.55% in 2023 before it tumbled 31.64% in 2024.
  • A 4-year view of Non-Current Assets shows it stood at $1.2 million in 2022, then crashed by 94.55% to $65949.0 in 2023, then crashed by 41.49% to $38588.0 in 2024, then crashed by 53.18% to $18068.0 in 2025.
  • Per Business Quant, the three most recent readings for COYA's Non-Current Assets are $18068.0 (Q3 2025), $24908.0 (Q2 2025), and $31748.0 (Q1 2025).